8-K: Venus Concept Cuts Debt by $11.48M, Extends Loan Maturity

Venus Concept Inc. reduced its debt by $11.48 million through a debt-to-equity exchange with Madryn, extended its Bridge Loan maturity, and increased its delayed draw commitment.

Summary

• Venus Concept Inc. (the Company) completed a debt-to-equity exchange with Madryn Health Partners, LP and Madryn Health Partners (Cayman Master), LP (collectively, Madryn) on September 30, 2025.
• The Company exchanged $11.48 million in subordinated convertible notes held by Madryn for 545,335 shares of its Series Y Convertible Preferred Stock.
• The Preferred Shares were priced at $21.05 per share, calculated based on the average closing price of the Company's common stock for the five trading days preceding the agreement, multiplied by a 9.0909 conversion factor.
• Following this transaction, the Company's total debt obligations decreased to approximately $30.1 million, representing a 24% reduction from $39.7 million outstanding as of December 31, 2024.
• The maturity date of the Bridge Loan was extended from September 30, 2025, to October 31, 2025.
• The delayed draw commitment under the Bridge Loan was increased from $21,000,000 to $26,000,000.
• Madryn consented to waive certain minimum liquidity requirements under the Main Street Priority Loan Agreement through October 31, 2025.
• The Company was permitted to pay the October 8, 2025, cash interest payment on the Main Street Priority Loan notes by adding it to the outstanding principal balance (PIK Interest Payment).
• The authorized shares of Series Y Preferred Stock were increased from 1,500,000 to 2,100,000.
• The Company is required to seek shareholder approval at the next meeting to eliminate limitations on the convertibility of the Series Y Preferred Stock under Nasdaq rules.

Sentiment

Score: 6

Explanation: The filing indicates a necessary financial restructuring to stabilize the company's balance sheet by reducing debt and extending maturities. While these are positive steps for financial flexibility, the underlying need for waivers on liquidity and PIK interest payments suggests ongoing operational challenges. The potential for future dilution from preferred stock conversion also tempers enthusiasm. It's a move towards stability, not immediate strong growth.

Positives

• Reduced total debt obligations by $11.48 million, leading to a 24% decrease from $39.7 million to approximately $30.1 million.
• Extended the maturity date of the Bridge Loan from September 30, 2025, to October 31, 2025, providing additional financial flexibility.
• Increased the delayed draw commitment under the Bridge Loan by $5,000,000, from $21,000,000 to $26,000,000, enhancing potential access to capital.
• Received a waiver from lenders for minimum liquidity requirements under the Main Street Priority Loan Agreement until October 31, 2025, easing immediate cash flow pressures.
• Obtained consent to pay the October 8, 2025, interest on the Main Street Priority Loan notes in kind (PIK) by adding it to the principal, preserving cash.

Negatives

• The debt-to-equity exchange involves the issuance of 545,335 shares of Series Y Preferred Stock, which, upon conversion, will result in dilution for existing common shareholders.
• The need for waivers on minimum liquidity requirements and the payment of interest in kind (PIK) suggest ongoing financial challenges and reliance on lender concessions.
• Shareholder approval is required to eliminate limitations on the convertibility of the Series Y Preferred Stock, introducing an element of uncertainty regarding full conversion.

Risks

• General economic conditions and other factors could materially affect business operations and financial performance.
• Risks and uncertainties described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and subsequent Quarterly Reports on Form 10-Q.
• Known and unknown risks, uncertainties, and other factors that are in some cases beyond the Company's control.
• Failure to obtain shareholder approval to eliminate limitations on the convertibility of the Series Y Preferred Stock under Nasdaq rules.
• Potential delisting of common stock from the Nasdaq Capital Market due to failure to comply with continued listing standards or a voluntary delisting without listing on another nationally recognized U.S. exchange.

Future Outlook

The company aims for sustained long-term growth, profitability, and the execution of its strategic initiatives, with the debt-to-equity exchange intended to advance its transformation plan. It will also seek shareholder approval to eliminate convertibility limitations for the Series Y Preferred Stock and file a shelf resale registration statement for the underlying common stock.

Management Comments

• Rajiv De Silva, CEO of Venus Concept: "Madryn’s invaluable partnership has provided us with financial flexibility as we work towards sustained long-term growth, profitability, and the execution of our strategic initiatives. The completion of an additional debt exchange reduces our overall debt balance and further optimizes our capital structure."
• Avinash Amin, MD, Managing Partner at Madryn Asset Management, LP: "We support Venus’ efforts to return to growth amidst a challenging market environment. The debt-to-equity exchange announced today is intended to advance Venus’ journey towards completing its transformation plan."

Industry Context

The announcement reflects a company in the medical aesthetic technology sector undergoing significant financial restructuring. The reference to a 'challenging market environment' by Madryn's managing partner suggests broader industry pressures or specific company-level challenges that necessitate such debt-to-equity conversions and loan extensions to maintain financial flexibility and support a 'transformation plan.'

Corporate Governance

Related Party Transactions

• The debt-to-equity exchange, loan amendments, and consent agreements were entered into with Madryn Health Partners, LP and Madryn Health Partners (Cayman Master), LP, who are existing lenders and holders of convertible notes, indicating related party transactions.

Stakeholder Impact

• Shareholders: Potential for future dilution from the conversion of Series Y Preferred Stock, but also benefit from a reduced debt burden and improved capital structure. Shareholder approval is required for full convertibility.
• Lenders (Madryn): Converted a portion of their debt into equity, extended the maturity of an existing loan, increased their delayed draw commitment, and received waivers on certain loan covenants, indicating continued support and a restructured investment.
• Company: Benefits from a significant reduction in outstanding debt, improved liquidity flexibility through waivers, extended loan maturity, and increased access to capital via the delayed draw commitment, supporting its transformation plan.

Next Steps

• The Company will include a proposal at the next annual or special meeting of shareholders to eliminate any limitations on the convertibility of the Series Y Preferred Stock under Nasdaq rules.
• The Company is required to file a shelf resale registration statement with the SEC within 60 days following the conversion of all issued and outstanding Series Y Preferred Stock into Common Stock.

Key Dates

Recommendation

The company is undergoing a necessary financial restructuring to improve its capital structure and liquidity. While the $11.48 million debt-to-equity exchange and the extension of the Bridge Loan maturity date provide immediate relief and flexibility, the need for waivers on minimum liquidity requirements and the payment of interest in kind (PIK) on other notes indicate ongoing financial challenges. The increased delayed draw commitment offers potential future capital, but also highlights continued reliance on external financing. The potential for significant dilution from the conversion of Series Y Preferred Stock, pending shareholder approval, adds uncertainty. This filing represents a stabilization effort rather than a clear path to immediate strong growth, suggesting a 'hold' position for investors to monitor the execution of the company's transformation plan and market conditions.

Keywords

Venus Concept, VERO, SEC Filing, 8-K, Debt-to-Equity Exchange, Convertible Notes, Preferred Stock, Bridge Loan, Loan Extension, Liquidity Waiver, Madryn Health Partners, Financial Restructuring, Capital Structure, Nasdaq